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Introduction: Syncope has myriad etiologies, ranging from benign to immediately life threatening. 
This frequently leads to over testing. Chest radiographs (CXR) are among these commonly performed 
tests despite their uncertain diagnostic yield. The objective is to study the distribution of normal and 
abnormal chest radiographs in patients presenting with syncope, stratified by those who did or did not 
have an adverse event at 30 days. 
  
Methods: We performed a post-hoc analysis of a prospective cohort of consecutive patients 
presenting to an urban tertiary care academic medical center with a chief complaint of syncope 
from 2003-2006. The frequency and findings for each CXR were reviewed, as well as emergency 
department and hospital discharge diagnoses, and 30-day outcome. 
 
Results: There were 575 total subjects, 39.7% were male, and the mean age was 57.2 (SD 24.6). Of 
the 575 subjects, 403 (70.1%) had CXRs performed, and 116 (20.2%) had an adverse event after their 
syncope. Of the 116 people who had an adverse event, 15 (12.9%) had a positive CXR, 81 (69.8%) 
had a normal CXR, and 20 (17.2%) did not have a CXR as part of the initial evaluation. Among the 459 
people who did not have an adverse event, 3 (0.7%) had a positive CXR, 304 (66.2%) had a normal 
CXR, and 152 (33.1%) did not have a CXR performed. Fifteen of the 18 patients (83.4%) with an 
abnormal CXR had an adverse event. Eighty-one of the 385 patients (21.0%) with a normal CXR had 
an adverse event. Among those who had a CXR performed, an abnormal CXR was associated with 
increased odds of adverse event (OR: 18.77 (95% CI= [5.3-66.4])).
 
Conclusion: Syncope patients with abnormal CXRs are likely to experience an adverse event, 
though the majority of CXRs performed in the work up of syncope are normal. [West J Emerg Med. 
2016;17(6)698-701.]
INTRODUCTION
Syncope is a common symptom of what is most often 
a benign disease process, but it may be a marker for a 
life-threatening illness. Syncope accounts for 740,000 
emergency department (ED) visits per year, an estimated 
3% of all ED patient visits, of whom 32% get admitted to 
the hospital. Similarly, up to 50% of patients presenting to 
Harvard Medical School, Beth Israel Deaconess Medical Center, Department of 
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the ED with syncope are discharged home from the hospital 
without an identifying etiology.1-3 This lack of diagnostic 
certainty often leads to over testing. Chest radiographs 
are among these commonly performed tests despite their 
uncertain diagnostic yield. 
The workup for syncope is often confused with 
the work up of patients with chest pain or myocardial 
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ischemia. Yet, syncope is rarely associated with myocardial 
ischemia.4-6 Prior studies have shown that other tests 
routinely used to evaluate ischemic etiologies of syncope, 
such as cardiac enzyme testing in syncope, are useful 
only in patients with concomitant signs and symptoms of 
cardiac ischemia or an electrocardiogram (EKG) suggestive 
of a ischemic etiology.4-6 Similarly, the utility of other 
cardiac testing in syncope such as echocardiography may 
be limited to those patients with an audible murmur, a 
history of valvular disease, or CXR or EKG suggestive of 
cardiomyopathy.6 CXR, routinely obtained in most standard 
cardiac “rule out” protocols as well, has unclear utility 
in assessing syncope for worrisome etiologies. As such, 
the objective of this study is to examine the frequency of 




Study Design and Setting
This is a secondary analysis of a prospective, 
observational, cohort study conducted in an urban 
teaching hospital with an annual ED census of 55,000 
as part of the original Boston Syncope Criteria study. 
Syncope was defined as a sudden and transient (<5 
minutes) loss of consciousness, producing a brief period 
of unresponsiveness and a loss of postural tone, ultimately 
resulting in spontaneous recovery requiring no resuscitation 
measures. More extensive details have been reported 
elsewhere.6-7 From September 2003 to June 2006 we 
studied consecutive patients presenting to the ED with 
syncope. Institutional review board approval was obtained 
prior to initiation of the study.
 
Selection of Participants
Inclusion criteria included patients aged 18 years or 
older who met our definition of syncope. 
 Exclusion criteria were persistent altered mental 
status, alcohol- or illicit drug-related loss of consciousness, 
seizure, coma, hypoglycemia, transient loss of 
consciousness caused by head trauma, or near syncope. We 
excluded patients with near syncope, including all patients 
without transient loss of consciousness, due to a lack of 
consensus regarding the definition of this entity.
Interventions
This study was observational; thus, the treating 
physicians were not directed to perform specific tests or 
work up. CXRs were ordered solely at the discretion of 
the treating physicians. All treatment decisions, including 
the necessity of a CXR, as well as the decision to admit 
the patient or not was at the sole discretion of the treating 
physician. An abnormal CXR was defined as a radiograph 
with findings consistent with congestive heart failure 
(CHF), pneumonia or pleural effusion.
Outcome Measures
 The primary outcome was the distribution of abnormal 
CXRs by serious adverse event. Serious adverse events 
were defined as death, pulmonary embolus, stroke, 
severe infection/sepsis, ventricular dysrhythmia, atrial 
dysrhythmia (including SVT [supraventricular tachycardia] 
and atrial fibrillation with rapid ventricular response), 
intracranial bleed, myocardial infarction pacemaker/
implantable cardiac defibrillator placement, percutaneous 
coronary intervention, or surgery, blood transfusion, cardiac 
arrest, alteration in antidysrhythmic therapy, endoscopy 
with intervention, or correction of carotid stenosis. Follow 
up was conducted at 30 days via telephone call and medical 
records review. In addition to review of in-hospital and 
post-discharge medical records, patients were queried as 
to whether they had additional testing following discharge 
to help avoid missing results of testing done outside of 
our institution. Findings were considered positive if based 
on the discharge summary the CXR was suggestive of 
the etiology of the patient’s syncope or contributed to an 
adverse event during the patient’s care. 
Data Collection and Processing
A trained research assistant available 16 hours per day 
prospectively screened patients with complaints of syncope 
or loss of consciousness and reviewed daily patient logs to 
ensure completion of documentation and to identify missed 
off-hour patients. Patients were identified in the ED either 
by research assistants or by the physician caring for that 
patient, although the attending physician made the final 
decision of whether the patient met enrollment criteria. The 
treating physician obtained informed consent and enrolled 
the patient. Approximately 50% of questionnaires were 
completed on initial ED evaluation, with the remainder 
completed shortly afterward. A study investigator or trained 
research assistant carried out follow-up phone calls with a 
structured follow-up form and medical record review at 30 
days after initial presentation to the ED to determine whether 
they had a further testing either in hospital or after discharge. 
All enrolled patients had at least one episode of 
syncope meeting the above definition to be eligible for 
enrollment. All adverse outcomes or clinical interventions, 
such as CPR, stroke, or cardiac arrest were noted after 
spontaneous recovery from the initial syncopal episodes. 
Outcomes were determined by inpatient diagnosis, 30-
day follow-up phone call, and subsequent medical records 
review.   
Primary Data Analysis
We queried the acquired dataset for patients who did 
or did not receive a CXR as part of their evaluation, as 
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well as for whether they suffered a 30-day adverse event. 
Standard numerical analysis was used for reporting means 
and standard deviations. 
RESULTS
There were 575 people in the cohort, of whom 39.65% were 
male, the mean age was 57.2 (SD 24.6), and 172 (29.9%) did not 
have a CXR performed at all (Table 1).
Out of the 575 subjects, 403 (70.1%) had a CXR performed, 
and 116 (20.2%) had an adverse event after their syncope. Of 
the 403 people who had CXR performed, 18 (4.5%) radiographs 
had abnormal findings. Among the 116 people who had adverse 
events, 20 (17.2%) did not have a CXR done, 81 (69.8%) had 
a normal CXR, and 15 (12.9%) had an abnormal CXR. Among 
the 459 people who did not have an adverse event, 152 (33.1%) 
did not have a CXR performed, 304 (66.2%) had a normal CXR, 
and 3 (0.7%) had an abnormal CXR. In the group of 15 that 
had an abnormal CXR and had an adverse event, 8 (53.3%) had 
CHF, 4 (26.7%) had pneumonia, 2 (13.3%) had CHF as well as 
pneumonia, and 1 (6.7%) had an effusion. See Table 2. Further 
hypothesis testing using standard frequentist approaches would 
be difficult to interpret given the low event rate, particularly in the 
setting of the study’s limitations.
DISCUSSION
The costs related to syncope-related hospital admissions 
total over $2 billion per year in the United States, and a large 
portion of these costs are directly related to diagnostic testing.1-3 
Mendu and others found the yield for testing in syncope to 
be under 5%, with the exception of orthostatic blood pressure 
measurements.8 Whether diagnostic tests, such as chest 
radiographs, have a similar lack of utility among ED patients 
with syncope remains unclear.
Abnormal CXRs were observed in 18 of the 575 
patients (3.1% overall, or 4.6% of those who had a CXR 
done), and 385 of the 575 patients (67.0% overall, or 
95.5% of those who had a CXR done.) Patients with an 
abnormal CXR were much more likely to have an adverse 
event than not (83.4% [60.0%-95.0%] vs. 16.7% [5.0% - 
40.1%]), and were at increased odds of having an adverse 
event compared to the group that had a normal CXR (OR 
[18.77], 95% CI [5.3-66.4], p<0.01) by Fisher’s exact test. 
All of the abnormal findings were from congestive heart 
failure, pneumonia, a combination of the two, or pleural 
effusion (Table 2). The majority of patients, however, 
either did not have a CXR performed (172/575, 29.9%) or 
had a normal CXR (385/575, 70.0%). In the subgroup of 
CXR Not performed CXR normal CXR abnormal
No adverse event 152
(33.1% [29.0% - 37.6%])
(88.3% [82.7% - 92.4%])
304
(66.2% [61.8 - 70.4%])
(79.0% [74.5% - 83.0%])
3
(0.7% [0.13% - 2%])
(16.7% [5.0% - 40.1%])
459
Adverse event 20
(17.2% [11.4% - 25.2%])
(11.6% [7.6% - 17.4%])
81
(69.8% [61.0% - 77.5%])
(21.0% [17.3% - 25.4%])
15
(13.0% [7.9% - 20.4%])
(83.4% [60.0% - 95.0%])
116
172 385 18 575
Table 1. Distribution of CXR performance and whether the patient experienced an adverse event, as well as row and columns percents, 
with 95% confidence intervals. 
CHF Pneumonia CHF & pneumonia Effusion
No adverse event 1
(33.3% [5.6% - 80.0%])
(11.11% [0% - 45.7%])
2
(67.7% [20.2% - 94.4%])
(33.3% [9.3% - 70.4%])
0
(0% [0% - 61.8%])
(0% [0% - 71.0%])
0
(0% [0% - 61.8%])
(0% [0% - 83.3%])
3
Adverse event 8
(53.3% [20.1% - 75.2%])
(88.9% [54.3% - 100%])
4
(26.7% [10.5% - 52.4%])
(66.7% [30.0% - 90.8%])
2
(13.3% [2.5% - 39.1%])
(100% [29.0% - 100%])
1
(6.7% [0% - 32.0%])
(100% [16.8% - 100%])
15
9 6 2 1 18
Table 2. Counts of abnormal CXR findings stratified by adverse event outcome, with row and column percentages with 95% confidence 
intervals. 
CXR, chest radiograph.
CXR, chest radiograph. CHF, congestive heart failure.
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patients who ultimately had a 30-day adverse event, most 
CXRs were normal. The patients who did not have a CXR 
performed appear to be much different than the patients who 
did have a CXR performed, demonstrated in Table 1, which 
reflects discretionary physician ordering. But this research is 
a reflection of clinical practice; when emergency physicians 
elect to order CXRs, an abnormal CXR is associated with 
an adverse event. This suggests some modest utility in 
the CXR in the work up of syncope. An abnormal finding 
on CXR should inform clinical decision-making as those 
patients are likely to have an adverse event. We therefore 
encourage the judicious use of CXRs in the proper clinical 
scenario.
LIMITATIONS
There are a number of limitations to this study. The 
discretionary performance of CXRs is a limitation that 
certainly introduces bias. Table 1 demonstrates that patients 
who did not have a CXR performed were much less 
likely to have an adverse event compared to the groups 
that had a normal CXR, as well as abnormal CXR. But at 
the same time the discretionary ordering reflects actual 
clinical practice. It seems unrealistic if not unethical to 
mandate diagnostic studies with ionization radiation for 
patients for whom the treating team does not think it 
justifiable or potentially helpful. Other limitations include 
the use of a single institution for a test site, which may 
limit the generalizability of the conclusions of this study. 
Furthermore, the sample size of this cohort is relatively 
small, as was the abnormal CXR rate, and there was a lack 
of long-term follow up in these patients. 
CONCLUSION
In ED patients with syncope, chest radiographs have 
modest diagnostic utility when ordered with discretion. 
Though the majority of patients who had an adverse event 
had a normal CXR, patients who had an abnormal CXR 
were at increased risk for an adverse event. When used in 
proper clinical context, there may be some information 
gained by performing a CXR in patients with syncope. A 
prospective study is needed to validate this conclusion. 
We recommend the judicious use of CXRs in the correct 
clinical setting.
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